uMotif Buys ClinOne

Engaged Patients. Better Trials.

uMotif provides the most modern eCOA/ePRO and engagement platform designed to power clinical and real-world research.

Designed in collaboration with patients to deliver unrivaled engagement-transforming the speed, quality and accuracy of data.

Delivering >90% compliance in real-world studies

By combining uMotif eCOA/ePRO with continuous glucose monitoring data capture, we delivered unprecedented data compliance rates for a pan-European diabetes study.



Reducing study timelines by 30%

In an immunology study, our patient-centered eCOA/ePRO solution helped the sponsor complete data capture requirements 6 months early.



High-quality endpoint data


In an FDA-required CNS study, we engaged participants to capture submission-ready ePRO through their own devices (BYOD).



Why are we unique? We’ve always designed for patients first.

At uMotif, we have a relentless focus on understanding the patient journey and what drives patient behavior.

This deep knowledge allows us to design software that best meets the needs of patients and delivers exceptionally high levels of engagement to study sponsors.

Powering patient-centered research.

Global

Delivering GCP compliant research at scale in over 30 countries

 

Multi-lingual

Available in any language, from Arabic to Japanese, French and Chinese

 

All therapy areas

Over 30 therapeutic areas

 

All study settings

Leading expertise spanning clinical, real-world and post-marketing

 
Jessica Morris

Founder, OurBrainBank

“Our key tool is the uMotif app. The app enables people to track their symptoms and treatments – an essential path to coping and surviving. Research shows that patients who self-track and share their data have better outcomes.”

Trusted by leading companies

across the globe.